{"id":"ssri-clomipramine","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dry mouth"},{"rate":"10-20%","effect":"Dizziness"},{"rate":"5-10%","effect":"Constipation"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Weight gain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By blocking the reuptake of these neurotransmitters, clomipramine increases their availability in the synaptic cleft, leading to increased neurotransmission and improved mood. This mechanism is characteristic of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs).","oneSentence":"Clomipramine is a tricyclic antidepressant that works by inhibiting the reuptake of serotonin and norepinephrine.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:36:04.993Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Obsessive-compulsive disorder"},{"name":"Major depressive disorder"}]},"trialDetails":[{"nctId":"NCT06942494","phase":"NA","title":"Effect of a Family-Based CBT Self-Help Intervention for Adolescents With OCD","status":"RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2025-04-30","conditions":"Obsessive - Compulsive Disorder","enrollment":88},{"nctId":"NCT02431845","phase":"NA","title":"Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder","status":"RECRUITING","sponsor":"Severance Hospital","startDate":"2013-01-01","conditions":"Obsessive-Compulsive Disorder","enrollment":200},{"nctId":"NCT05952713","phase":"","title":"Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder","status":"COMPLETED","sponsor":"Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital","startDate":"2022-10-01","conditions":"Major Depressive Disorder","enrollment":73336},{"nctId":"NCT02450695","phase":"NA","title":"rTMS in Treatment Refractory Obsessive-Compulsive Disorder","status":"WITHDRAWN","sponsor":"McMaster University","startDate":"2016-07","conditions":"Obsessive-Compulsive Disorder","enrollment":""},{"nctId":"NCT00564564","phase":"PHASE4","title":"Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-compulsive Disorder Patients","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2006-01","conditions":"Obsessive Compulsive Disorder","enrollment":21},{"nctId":"NCT00074815","phase":"PHASE3","title":"Treatment of Obsessive Compulsive Disorder in Children","status":"COMPLETED","sponsor":"Duke University","startDate":"2003-09","conditions":"Obsessive-Compulsive Disorder","enrollment":124},{"nctId":"NCT00944996","phase":"NA","title":"Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression","status":"COMPLETED","sponsor":"Tirat Carmel Mental Health Center","startDate":"2009-06","conditions":"Major Depression","enrollment":100},{"nctId":"NCT00254735","phase":"PHASE3","title":"Quetiapine Augmentation in Severe Obsessive Compulsive Disorder","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2002-04","conditions":"Obsessive Compulsive Disorder","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"SSRI/Clomipramine","genericName":"SSRI/Clomipramine","companyName":"AstraZeneca","companyId":"astrazeneca","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clomipramine is a tricyclic antidepressant that works by inhibiting the reuptake of serotonin and norepinephrine. Used for Obsessive-compulsive disorder, Major depressive disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}